A detailed history of Financial Network Wealth Advisors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 113 shares of CSTL stock, worth $3,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113
Holding current value
$3,745
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $2,128 - $2,818
113 New
113 $2.46 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $872M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Financial Network Wealth Advisors LLC Portfolio

Follow Financial Network Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Network Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Network Wealth Advisors LLC with notifications on news.